{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:46:34Z","timestamp":1790725594716,"version":"4.1.0"},"publisher-location":"Cham","reference-count":7,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031044014","type":"print"},{"value":"9783031044021","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-3-031-04402-1_7","type":"book-chapter","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T10:08:30Z","timestamp":1669802910000},"page":"103-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rituximab-Associated Progressive Multifocal Leukoencephalopathy: A Twenty-Year Update"],"prefix":"10.1007","author":[{"given":"Charles L.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartlett","family":"Witherspoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"issue":"Suppl 2","key":"7_CR1","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.3949\/ccjm.78.s2.04","volume":"78","author":"CL Bennett","year":"2011","unstructured":"Bennett CL (2011) Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med 78(Suppl 2):S13\u2013S17","journal-title":"Cleve Clin J Med"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","volume":"113","author":"KR Carson","year":"2009","unstructured":"Carson KR, Evens AM, Richey EA, Habermann TM, Focosi D, Seymour JF, Laubach J, Bawn SD, Gordon LI, Winter JN, Furman RR, Vose JM, Zelenetz AD, Mamtani R, Raisch DW, Dorshimer GW, Rosen ST, Muro K, Gottardi-Littell NR, Talley RL, Sartor O, Green D, Major EO, Bennett CL (2009) Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 113:4834\u20134840","journal-title":"Blood"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","volume":"10","author":"KR Carson","year":"2009","unstructured":"Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL (2009) Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 10:816\u2013824","journal-title":"Lancet Oncol"},{"key":"7_CR4","unstructured":"Data on file (Genentech, Incorporated)"},{"key":"7_CR5","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1002\/art.22657","volume":"56","author":"LH Calabrese","year":"2007","unstructured":"Calabrese LH, Molloy ES, Huang D et al (2007) Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum 56:2116\u20132128","journal-title":"Arthritis Rheum"},{"key":"#cr-split#-7_CR6.1","doi-asserted-by":"crossref","unstructured":"Boddy CS, Bennett CL, Norris LB, et al (2014) Rituximab-associated progressive multifocal leukoencephalopathy (PML) in HIV-negative patients: an updated report of 231 confirmed cases from the Southern Network on Adverse Reactions (SONAR)\/Washington University collaboration (2000-2012). Presented at the 56th ASH Annual Meeting and Exposition in San Francisco, CA","DOI":"10.1182\/blood.V124.21.4456.4456"},{"key":"#cr-split#-7_CR6.2","unstructured":"December 6-9, 2014. ASH Abstract #4456. http:\/\/www.hematology.org\/Annual-Meeting\/"}],"container-title":["Cancer Treatment and Research","Cancer Drug Safety and Public Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-04402-1_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T10:09:18Z","timestamp":1669802958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-04402-1_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031044014","9783031044021"],"references-count":7,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-04402-1_7","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"value":"0927-3042","type":"print"},{"value":"2509-8497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"1 December 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}